Chinook Therapeutics, Inc. KDNY
40.39 +40.39
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 6.13M | 51.63M | 827.00K | 0 | 15.09M | |
| 6.13M | 51.63M | 827.00K | 0 | 15.09M | |
| -185.08M | -99.04M | -56.23M | -19.97M | -101.36M | |
| -187.87M | -102.94M | -81.62M | -46.52M | -95.36M | |
| -2.92 | -2.26 | -6.20 | -25.48 | -6.05 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 117.51M | 183.80M | 189.50M | 11.36M | 126.78M | |
| 574.08M | 563.80M | 429.00M | 15.72M | 357.50M | |
| 132.14M | 110.16M | 94.38M | 37.01M | 222.19M | |
| 39.44M | 43.99M | 41.75M | 2.08M | 0 | |
| 441.94M | 453.64M | 334.62M | -41.12M | 135.31M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -117.48M | -102.74M | -55.85M | -13.59M | -68.76M | |
| -99.99M | -112.64M | 109.67M | -758.00K | 39.41M | |
| 151.43M | 209.52M | 124.29M | 25.69M | -1.50M | |
| -1.65M | -1.61M | -647.00K | -758.00K | -2.32M | |
| -66.29M | -5.70M | 178.14M | 11.36M | -31.30M |